You are hereBiblio / Gene Therapy Oversight: Lessons for Nanobiotechnology

Gene Therapy Oversight: Lessons for Nanobiotechnology


By csep - Posted on 27 September 2010

TitleGene Therapy Oversight: Lessons for Nanobiotechnology
Publication TypeJournal Article
Year of Publication2009
AuthorsWolf, Susan M., Gupta Rishi, and Kohlhepp Peter
JournalJournal of Law, Medicine & Ethics
Volume37
Issue4
Pagination659-684
Date PublishedWinter2009
Type of ArticleArticle
Publication Languageeng
ISSN Number10731105
Accession Number46823895
KeywordsBIOTECHNOLOGY, GENE therapy, GENETIC transformation, MEDICINE -- Research, NANOTECHNOLOGY, RESEARCH, TECHNOLOGICAL innovations
Abstract

The authors discuss how the oversight of human gene transfer research presents an important model with potential application to oversight of nanobiology research on human participants. This article traces the evolution of the dual oversight system currently in place for gene therapy; describes how the system is already addressing nanobiotechnology in gene transfer: evaluates gene therapy oversight based on public opinion, the literature, and preliminary expert elicitation; and offers lessons of the gene therapy oversight experience for oversight of nanobiotechnology.

Notes

Wolf, Susan M. 1 Gupta, Rishi 2 Kohlhepp, Peter 3; Affiliation: 1: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law; Professor of Medicine; and Faculty Member in the Center for Bioethics at the University of Minnesota. 2: Holds an M.S. in Applied Physics from the University of Texas at Dallas and a J.D. from the University of Minnesota Law School. He is currently an Associate at Fish and Richardson PC. in Dallas, Texas. 3: Received his J.D. from the University of Minnesota Law School in May 2009. He is currently an Associate at Carlson, Caspers, Vandenburgh and Lindquist in Minneapolis.; Source Info: Winter2009, Vol. 37 Issue 4, p659; Subject Term: GENE therapy; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: TECHNOLOGICAL innovations; Subject Term: GENETIC transformation; Subject Term: RESEARCH; Subject Term: MEDICINE -- Research; NAICS/Industry Codes: 541712 Reseach and Development in the Physical, Engineering, and Life Sciences (except Biotechnology); Number of Pages: 26p; Illustrations: 3 Charts; Document Type: Article

DOI10.1111/j.1748-720X.2009.00439.x